Testing effectiveness (Phase 2)Study completedNCT03379844
What this trial is testing
HEPAR Primary: Holmium-166-radioembolization in Hepatocellular Carcinoma Patients
Who this might be right for
Hepatocellular CarcinomaHepatocellular Carcinoma Non-resectable
UMC Utrecht 30